New York State Healthcare Provider Education: Medical Use of Marijuana

New York State Department of Health
Primary Course Director: Jeffrey Hergenrather, MD
Co-Director: Michelle Sexton, ND

$229.00

Credit Available

This course offers up to 4 AMA PRA Category 1 Credits™ and 4 ACPE Accreditation Hours

You Will Learn About

  • The New York State Medical Marijuana Program
  • The Endocannabinoid System
  • Pharmacology of Cannabis
  • Delivery and Dosage of Cannabis Medicine
  • Cannabis in Movement and Digestive Disorders, Neurodegenerative Diseases, Cancer, Pain, Immune Deficiency Syndromes

Developed by the Society of Cannabis Clinicians (SCC) and approved by the New York State Department of Health (NYSDOH), this online CME-certified curriculum is designed to educate practitioners who wish to register with the Department to certify patients for the medical use of marijuana under New York State’s Compassionate Care Act as well as pharmacists who will be working in dispensing facilities of registered organizations. Certified for 4 AMA PRA Category 1 Credits™ and 4 ACPE Credits.

Click for Credit Information

Purchase grants one learner one year’s access to lessons and quizzes (access expires 365 days from date of course activation).

NOTE: Bulk pricing is available! Call 844.490.2569 or email info@tmciglobal.org.

Registration Instructions from the New York State Department of Health:

Physicians, Nurse Practitioners and Physician Assistants seeking to register with the New York State Department of Health (NYSDOH) to certify patients for medical marijuana must complete a NYSDOH approved Medical Use of Marijuana course. Pharmacists working in dispensing facilities must successfully complete a NYSDOH approved Medical Use of Marijuana course before they may counsel, or supervise another employee who may counsel certified patients and designated caregivers on the use, administration, and risks associated with approved medical marijuana products.

Practitioners who have completed the course and who wish to register with NYSDOH to certify patients for medical marijuana must email the course completion certificate (in PDF format) to NYSDOH at mmp@health.ny.gov, along with the practitioner’s State License number and Health Commerce System (HCS) User ID. Upon validation of the information provided, NYSDOH will send an email confirmation to the practitioner containing instructions for completing their registration. Practitioners may not certify patients for medical marijuana until they receive confirmation from NYSDOH that they are registered to do so.

Lesson Plan

The Endocannabinoid System

  • The basic function of the endocannabinoid system in various tissues, organs, and body systems.
  • The physiologic effect of cannabis on body systems and the side effects of cannabis that patients may experience.

Pharmacology of Cannabis

  • The pharmacokinetics of cannabis absorption, distribution, metabolism and elimination in order to facilitate patient treatment.

Cannabis Use Disorders and Precautions; Delivery and Dosage of Cannabis Medicine

  • The differences in the absorption and metabolism rates with different methods of cannabis administration in patient treatment.
  • Cannabis dependence, addiction, tolerance, and withdrawal.
  • Six common delivery systems and dosage considerations for medical cannabis in order to facilitate patient treatment.

Cannabis in Movement Disorders, Neuropathies, Cancer, Pain, Digestive Disorders and Immune Deficiency Syndromes

  • The utility of cannabis in symptom management in cancer patients.
  • The physiological mechanisms by which cannabinoids may be therapeutic for neurodegenerative disorders.
  • The use of cannabis for the following severe, debilitating or life-threatening conditions:  cancer, HIV infection or AIDS, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, multiple sclerosis, spinal cord injury with spasticity, epilepsy, inflammatory bowel disease, neuropathy, Huntington’s disease and chronic pain.  The severe, debilitating or life-threatening condition must be accompanied by cachexia or wasting syndrome, severe or chronic pain, severe nausea, seizures, or severe or persistent muscle spasms.

hergenrather150x150

Primary Course Director: 
Jeffrey Hergenrather, MD

michelle-sexton-138x138

Co-Director:
Michelle Sexton, ND

Contributing Faculty Members:
  • Dustin Sulak, DO
  • Laura Borgelt, PharmD, FCCP, BCPS
  • Deborah Malka, MD, PhD
  • Mary Lynn Mathre, RN, MSN, CARN
  • John McPartland, DO
  • Donald Abrams, MD
  • Michelle Sexton, ND
  • Jeffrey Hergenrather, MD
  • Stacey Marie Kerr, MD
  • Arnold Leff, MD
  • Sydney J. Kurn, MD